The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity
Open accessAbstract
The mutational repertoire of cancers creates the neoepitopes that make cancers immunogenic. Here, we introduce two novel tools that identify, with relatively high accuracy, the small proportion of neoepitopes (among the hundreds of potential neoepitopes) that protect the host through an antitumor T cell response. The two tools consist of (a) the numerical difference in NetMHC scores between the mutated sequences and their unmutated counterparts, termed the differential agretopic index, and (b) the conformational stability of the MHC I–peptide interaction. Mechanistically, these tools identify neoepitopes that are mutated to create new anchor residues for MHC binding, and render the overall peptide more rigid. Surprisingly, the protective neoepitopes identified here elicit CD8-dependent immunity, even though their affinity for Kd is orders of magnitude lower than the 500-nM threshold considered reasonable for such interactions. These results greatly expand the universe of target cancer antigens and identify new tools for human cancer immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome.
Langmead, B., Trapnell, C., Pop, M., & Salzberg, S. L. (2009) · Genome Biology · doi:10.1186/gb-2009-10-3-r25 · Cited by 21,849
Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences
Cohen, P., Cohen, P., West, S. G., & Aiken, L. S. (2014) · Psychology Press eBooks · doi:10.4324/9781410606266 · Cited by 20,737
The Amber biomolecular simulation programs
Case, D. A., Cheatham, T. E., Darden, T., Gohlke, H., Luo, R., Merz, K. M., Onufriev, A., Simmerling, C., Wang, B., & Woods, R. J. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20290 · Cited by 9,535
Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences
Kemp, F. (2003) · Journal of the Royal Statistical Society: Series D (The Statistician) · doi:10.1046/j.1467-9884.2003.t01-2-00383_4.x · Cited by 9,293
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Routine Microsecond Molecular Dynamics Simulations with AMBER on GPUs. 1. Generalized Born
Götz, A. W., Williamson, M. J., Xu, D., Poole, D., Le Grand, S., & Walker, R. C. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct200909j · Cited by 2,046
Protein Structure Modeling with MODELLER
Eswar, N., Eramian, D., Webb, B., Shen, M.-Y., & Sali, A. (2008) · Methods in Molecular Biology · doi:10.1007/978-1-60327-058-8_8 · Cited by 1,773
The Concept of Immunological Surveillance
Burnet, F. M. (2015) · Progress in Tumor Research · doi:10.1159/000386035 · Cited by 1,656
Mouse genomic variation and its effect on phenotypes and gene regulation.
Keane, T. M., Goodstadt, L., Danecek, P., White, M. A., Wong, K., Yalcin, B., Heger, A., Agam, A., Slater, G., Goodson, M., et al. (2011) · Nature · doi:10.1038/nature10413 · Cited by 1,580
Identification of host proteins required for HIV infection through a functional genomic screen
Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., & Elledge, S. J. (2008) · Science · doi:10.1126/science.1152725 · Cited by 1,449
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Matsushita, H., Vesely, M. D., Koboldt, D. C., Rickert, C. G., Uppaluri, R., Magrini, V. J., Arthur, C. D., White, J. M., Chen, Y.-S., Shea, L. K., et al. (2012) · Nature · doi:10.1038/nature10755 · Cited by 1,288
Analyzing and minimizing PCR amplification bias in Illumina sequencing libraries
Aird, D., Ross, M. G., Chen, W.-S., Danielsson, M., Fennell, T., Russ, C., Jaffe, D. B., Nusbaum, C., & Gnirke, A. (2011) · Genome Biology · doi:10.1186/gb-2011-12-2-r18 · Cited by 1,174
CTLA-4: new insights into its biological function and use in tumor immunotherapy
Egen, J. G., Kuhns, M. S., & Allison, J. P. (2002) · Nature Immunology · doi:10.1038/ni0702-611 · Cited by 940
Exploiting the Mutanome for Tumor Vaccination
Castle, J. C., Kreiter, S., Diekmann, J., Löwer, M., van de Roemer, N., de Graaf, J., Selmi, A., Diken, M., Boegel, S., Paret, C., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3722 · Cited by 810
van Rooij, N., van Buuren, M. M., Philips, D., Velds, A., Toebes, M., Heemskerk, B., van Dijk, L. J. A., Behjati, S., Hilkmann, H., el Atmioui, D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.7521 · Cited by 798
Protein Structure Modeling with MODELLER
Webb, B., & Sali, A. (2014) · Methods in Molecular Biology · doi:10.1007/978-1-4939-0366-5_1 · Cited by 549
Exome sequencing identifies GRIN2A as frequently mutated in melanoma
Program, N. C. S., Wei, X., Walia, V., Lin, J. C., Teer, J. K., Prickett, T. D., Gartner, J., Davis, S., Stemke-Hale, K., Davies, M. A., et al. (2011) · Nature Genetics · doi:10.1038/ng.810 · Cited by 471
Cao, K., Hollenbach, J., Shi, X., Shi, W., Chopek, M., & Fernández-Viña, M. A. (2001) · Human Immunology · doi:10.1016/s0198-8859(01)00298-1 · Cited by 465
The response of autologous T cells to a human melanoma is dominated by mutated neoantigens
Lennerz, V., Fatho, M., Gentilini, C., Frye, R. A., Lifke, A., Ferel, D., Wölfel, C., Huber, C., & Wölfel, T. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500090102 · Cited by 456
Epitope Landscape in Breast and Colorectal Cancer
Segal, N. H., Parsons, D. W., Peggs, K. S., Velculescu, V., Kinzler, K. W., Vogelstein, B., & Allison, J. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-3095 · Cited by 416
Ding, Y.-H., Baker, B. M., Garboczi, D. N., Biddison, W. E., & Wiley, D. C. (1999) · Immunity · doi:10.1016/s1074-7613(00)80080-1 · Cited by 363
Self-citationRen, S., Peng, Z., Mao, J.-H., Yu, Y., Yin, C., Gao, X., Cui, Z., Zhang, J., Yi, K., Xu, W., et al. (2012) · Cell Research · doi:10.1038/cr.2012.30 · Cited by 362
Eradication of Established Tumors by CD8+ T Cell Adoptive Immunotherapy
Hanson, H. L., Donermeyer, D. L., Ikeda, H., White, J. M., Shankaran, V., Old, L. J., Shiku, H., Schreiber, R. D., & Allen, P. M. (2000) · Immunity · doi:10.1016/s1074-7613(00)00026-1 · Cited by 358
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
Rajasagi, M., Shukla, S. A., Fritsch, E. F., Keskin, D. B., DeLuca, D., Carmona, E., Zhang, W., Sougnez, C., Cibulskis, K., Sidney, J., et al. (2014) · Blood · doi:10.1182/blood-2014-04-567933 · Cited by 309
Self-citation(1978) · Elsevier eBooks · doi:10.1016/b978-0-12-507850-4.x5001-x · Cited by 261
Two complementary methods for predicting peptides binding major histocompatibility complex molecules
Gulukota, K., Sidney, J., Sette, A., & DeLisi, C. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.0937 · Cited by 259
Self-citationLundegaard, C., Lund, O., & Nielsen, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn128 · Cited by 250
Anti–CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy
Callahan, M. K., Wolchok, J. D., & Allison, J. P. (2010) · Seminars in Oncology · doi:10.1053/j.seminoncol.2010.09.001 · Cited by 245
Database of T cell-defined human tumor antigens: the 2013 update.
Vigneron, N., Stroobant, V., den Eynde, B. J. V., & van der Bruggen, P. (2013) · Europe PMC (PubMed Central) · Cited by 226
Assarsson, E., Sidney, J., Oseroff, C., Pasquetto, V., Bui, H.-H., Frahm, N., Brander, C., Peters, B., Grey, H., & Sette, A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7890 · Cited by 191
Self-citationHLA-Binding Properties of Tumor Neoepitopes in Humans
Fritsch, E. F., Rajasagi, M., Ott, P. A., Brusic, V., Hacohen, N., & Wu, C. J. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0227 · Cited by 190
van der Most, R. G., Sette, A., Oseroff, C., Alexander, J., Murali-Krishna, K., Lau, L. L., Southwood, S., Sidney, J., Chesnut, R. W., Matloubian, M., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5543 · Cited by 181
Self-citationAntigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases
Corbière, V., Chapiro, J., Stroobant, V., Ma, W., Lurquin, C., Lethé, B., van Baren, N., Van den Eynde, B. J., Boon, T., & Coulie, P. G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2693 · Cited by 175
(1993) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60318-8 · Cited by 166
Lu, Y., Yao, X., Li, Y. F., El‐Gamil, M., Dudley, M. E., Yang, J. C.-H., Almeida, J. R., Douek, D. C., Samuels, Y., Rosenberg, S. A., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202830 · Cited by 154
Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture
Sidney, J., Southwood, S., Moore, C., Oseroff, C., Pinilla, C., Grey, H. M., & Sette, A. (2013) · Current Protocols in Immunology · doi:10.1002/0471142735.im1803s100 · Cited by 146
Self-citationsnpTree - a web-server to identify and construct SNP trees from whole genome sequence data
Leekitcharoenphon, P., Kaas, R. S., Thomsen, M. C. F., Friis, C., Rasmussen, S., & Aarestrup, F. M. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-s7-s6 · Cited by 112
Mutated mitogen-activated protein kinase: A tumor rejection antigen of mouse sarcoma
Ikeda, H., Ohta, N., Furukawa, K., Miyazaki, H., Wang, L., Furukawa, K., Kuribayashi, K., Old, L. J., & Shiku, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6375 · Cited by 99
Modeling mutations in protein structures
Feyfant, E., Sali, A., & Fiser, A. (2007) · Protein Science · doi:10.1110/ps.072855507 · Cited by 95
Borbulevych, O. Y., Insaidoo, F. K., Baxter, T. K., Powell, D. J., Johnson, L. A., Restifo, N. P., & Baker, B. M. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.07.025 · Cited by 94
Self-citationSharma, A. K., Kuhns, J. J., Yan, S., Friedline, R. H., Long, B., Tisch, R., & Collins, E. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010791200 · Cited by 69
Area under the curve as a tool to measure kinetics of tumor growth in experimental animals
Duan, F., Simeone, S., Wu, R., Grady, J., Măndoiu, I., & Srivastava, P. K. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2012.06.005 · Cited by 67
Self-citationInsaidoo, F. K., Borbulevych, O. Y., Hossain, M., Santhanagopolan, S. M., Baxter, T. K., & Baker, B. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.283564 · Cited by 55
Self-citationMarkiewicz, M. A., Fallarino, F., Ashikari, A. Y., & Gajewski, T. F. (2001) · International Immunology · doi:10.1093/intimm/13.5.625 · Cited by 50
Duitama, J., Srivastava, P. K., & Măndoiu, I. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-s2-s6 · Cited by 49
Self-citationPeptide database of T-cell defined tumor antigens
van der Bruggen, P., Stroobant, V., Vigneron, N., & den Eynde, B. J. V. (2013) · Digital Access to Libraries · Cited by 46
Modeling the Repertoire of True Tumor-Specific MHC I Epitopes in a Human Tumor
Srivastava, N., & Srivastava, P. K. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006094 · Cited by 28
Self-citationStructural Definition of the H-2Kd Peptide-binding Motif
Mitaksov, V., & Fremont, D. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510511200 · Cited by 28
Zhou, M., Xu, Y., Lou, Z., Cole, D. K., Li, X., Liu, Y., Tien, P., Rao, Z., & Gao, G. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904013587 · Cited by 28
“It is the antigen(s), stupid” and other lessons from over a decade of vaccitherapy of human cancer
Buckwalter, M. R., & Srivastava, P. K. (2008) · Seminars in Immunology · doi:10.1016/j.smim.2008.07.003 · Cited by 24
Self-citationAccurate structure prediction of peptide–MHC complexes for identifying highly immunogenic antigens
Park, M.-S., Park, S. Y., Miller, K. R., Collins, E. J., & Lee, H. Y. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.04.011 · Cited by 16
Immune Rejection of Mouse Tumors Expressing Mutated Self
Duan, F., Lin, Y., Liu, C., Engelhorn, M. E., Cohen, A. D., Curran, M. A., Sakaguchi, S., Merghoub, T., Terzulli, S. L., Wolchok, J. D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2779 · Cited by 15
Self-citation
Cited by
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
A guide to cancer immunotherapy: from T cell basic science to clinical practice
Waldman, A. D., Fritz, J. M., & Lenardo, M. J. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0306-5 · Cited by 4,154
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286
Cancer immunoediting and resistance to T cell-based immunotherapy
O’Donnell, J. S., Teng, M. W. L., & Smyth, M. J. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0142-8 · Cited by 1,759
Metadata
- Authors
- Duan, F., Duitama, J., Al Seesi, S., Ayres, C. M., Corcelli, S. A., Pawashe, A. P., Blanchard, T., McMahon, D., Sidney, J., Sette, A., Baker, B. M., Mandoiu, I. I., & Srivastava, P. K.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2014-09-22
- Volume
- 211
- Issue
- 11
- Pages
- 2231-2248
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2140235037
- Cited by
- 378
- References
- 54
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.